Myasthenia gravis (MG) is a drawn out neuromuscular illness that prompts differing degrees of skeletal muscle shortcoming. The most usually influenced muscles are those of the eyes, face, and gulping. It can bring about twofold vision, hanging eyelids, inconvenience talking, and inconvenience strolling. Beginning can be unexpected. Myasthenia gravis is commonly rewarded with meds referred to as acetylcholinesterase inhibitors, for example, neostigmine and pyridostigmine. Immunosuppressants, for example, prednisone or azathioprine, may likewise be utilized. The careful evacuation of the thymus may improve indications in specific cases. Plasmapheresis and high portion intravenous immunoglobulin might be utilized during unexpected flares of the condition. On the off chance that the breathing muscles become essentially feeble, mechanical ventilation might be required. Once intubated acetylcholinesterase inhibitors might be briefly held to lessen aviation route emissions.
Case Report: Neurological Disorders
Case Report: Neurological Disorders
Letter to Editor: Neurological Disorders
Letter to Editor: Neurological Disorders
Editorial: Neurological Disorders
Editorial: Neurological Disorders
Case Report: Neurological Disorders
Case Report: Neurological Disorders
Research Article: Neurological Disorders
Research Article: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Scientific Tracks Abstracts: Neurological Disorders
Scientific Tracks Abstracts: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Scientific Tracks Abstracts: Journal of Spine
Scientific Tracks Abstracts: Journal of Spine
Neurological Disorders received 1343 citations as per Google Scholar report